SomnoMed Limited
SOM
Rank in Stocks
#22744
SomnoMed Limited, together with its subsidiaries, produce and sells devices for... SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Share Price
$0.21776633
Last synced: 2026-11-13
Market Cap
$47.73M
Change (1 day)
9.72%
Change (1 year)
-57.24%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade SomnoMed Limited (SOM)
Category
Healthcare
Operating Margin for SomnoMed Limited (SOM)
Operating Margin as of November 2026 TTM: 0.85%
According to SomnoMed Limited's latest financial reports, its current operating margin (TTM) is 0.85%. At the end of 2025 the company had an operating margin of 3.24%.
Operating Margin history for SomnoMed Limited from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.85% | -73.77% |
| 2025 | 3.24% | -135.64% |
| 2024 | -9.09% | 86.65% |
| 2023 | -4.87% | -14.41% |
| 2022 | -5.69% | 447.12% |
| 2021 | -1.04% | -36.59% |
| 2020 | -1.64% | -205.13% |
| 2019 | 1.56% | -59.27% |
| 2018 | 3.83% | -150.59% |
| 2017 | -7.57% | -2,903.70% |
| 2016 | 0.27% | 125.00% |
| 2015 | 0.12% | -88.46% |
| 2014 | 1.04% | -6.31% |
| 2013 | 1.11% | -62.88% |
| 2012 | 2.99% | -28.30% |
| 2011 | 4.17% | 2,352.94% |
| 2010 | 0.17% | -100.69% |
| 2009 | -24.63% | -68.64% |
| 2008 | -78.55% | -52.44% |
| 2007 | -165.15% | -35.24% |
| 2006 | -255.03% | -73.52% |
| 2005 | -963.18% | -51.90% |
| 2004 | -2,002.54% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.00% | -82.35% |
US
|
|
| 18.08% | -78.73% |
IE
|
|
| 21.25% | -75.00% |
US
|
|
| 21.05% | -75.24% |
US
|
|
| 25.52% | -69.98% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SomnoMed Limited's operating margin
What is SomnoMed Limited's operating margin?
SomnoMed Limited's operating margin is 0.85%, as of Nov 2026.
What was SomnoMed Limited's operating margin in 2025?
In 2025, SomnoMed Limited's operating margin was 3.24%, compared with -9.09% in 2024.
How has SomnoMed Limited's operating margin changed since 2020?
From 2020 to 2025, SomnoMed Limited's operating margin was highest in 2025 (3.24%) and lowest in 2024 (-9.09%).
How does SomnoMed Limited's operating margin compare with similar companies?
SomnoMed Limited's operating margin (0.85%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 25.52%.